Front Page VSPN Message Boards Chat Library Continual Education Search MyVSPN - Coming Soon Help Frequently Asked Questions Send us Feedback! Go to VIN Industry Partners Go to VetQuest Go to Veterinary Partner Go to Y2Spay
 
Menu bar   Go to the VIN.com Portal
 

ABSTRACT OF THE WEEK

Veterinary ophthalmology
Volume 24 Suppl 1 | Issue 0 (March 2021)

Pharmacologic ciliary body ablation for chronic glaucoma in dogs: A retrospective review of 108 eyes from 2013 to 2018.

Vet Ophthalmol. March 2021;24 Suppl 1(0):125-130.
Martha E Julien1, Simone A Schechtmann2, Tammy M Michau3, Anja Welihozkiy4, Terri L Baldwin5, Jessica M Stine6
1 BluePearl Veterinary Partners, Tampa, FL, USA.; 2 BluePearl Veterinary Partners, Tampa, FL, USA.; 3 BluePearl Veterinary Partners, Tampa, FL, USA.; 4 BluePearl Veterinary Partners, Sarasota, FL, USA.; 5 BluePearl Veterinary Partners, Clearwater, FL, USA.; 6 BluePearl Veterinary Partners, Clearwater, FL, USA.
© 2020 American College of Veterinary Ophthalmologists.

Abstract

OBJECTIVE:To evaluate the long-term outcome and efficacy of intravitreal injection of gentamicin and dexamethasone sodium phosphate (IVGD) or triamcinolone in end-stage glaucoma patients and determine pre-procedure prognostic indicators of success and post-operative complications.
PROCEDURE:Medical records were reviewed for 108 dogs (108 eyes) treated with intravitreal gentamicin with or without dexamethasone sodium phosphate or triamcinolone for glaucoma between 2013 and 2018 with 3 months of minimum follow-up. Signalment and clinical findings, including type of glaucoma, pre-procedure intraocular pressure (IOP), chronicity, procedure protocol, and outcome were recorded. Success was defined as an intraocular pressure of ≤25 mm Hg at the time of last re-examination or no ocular hypotensive medications at 3 months or longer post-injection.
RESULTS:The overall success rate for pharmacologic ablation was 95%. The success rate for dogs receiving no ocular hypotensive medications was 86%. Seventy-six eyes (70.4%) had primary glaucoma, and 32 eyes (29.6%) had secondary glaucoma. Age at the time of injection had no effect on initial success but did in final success (P =-.03) for dogs requiring repeat injections. Cocker Spaniels required the most repeat 2nd and 3rd injections (3/12 dogs) and (2/4 dogs), respectively. No preoperative variable significantly affected the success rate. The most common complications were phthisis bulbi (59.2%), corneal edema (25.9%), and ulcerative keratitis (22.3%). Uncontrolled IOP resulted in enucleation in two dogs (1.8%).
CONCLUSIONS:Pharmacologic ablation has a high overall success rate in lowering IOP to ≤25 mm Hg short-term in blind, glaucomatous canine eyes. Type of glaucoma, pre-procedure IOP, chronicity, and protocol did not affect success.

Companion Notes

Retrospective report on pharmacologic ciliary body ablation for chronic glaucoma in 108 dogs

- intravitreal gentamicin and dexamethasone sodium phosphate or triamcinolone

   

Introduction on the treatment of chronic glaucoma

- primary glaucoma is typically genetic

(bilateral with predisposition for certain breeds)

- has 2 main forms based on gonioscopy of the drainage angle

- primary open angle glaucoma

- primary closed angle glaucoma

- secondary glaucoma is associated with ocular and systemic diseases

- painful and difficult to manage with medical and surgical intervention

- pharmacologic ablation of the ciliary body or ciliary body ablation (CBA)

- generally doesn’t require anesthesia

- owners may prefer it cosmetically compared to enucleation or evisceration

- procedure involves vitreocentesis

- followed by an injection of dexamethasone sodium phosphate

- in conjunction with a recommended dose of 15-30 mg gentamicin

- gentamicin is toxic to the ciliary body epithelium

- previously reported success rate in lowering IOP: 65%

- 86.4% reported more recently for ciliary body ablation with gentamicin

   

Study design

- study population: dogs seen at ophthalmology service of 4 referral hospitals

- inclusion criteria:

- end-stage glaucoma

- chronic glaucomatous, avisual eyes refractory to medical therapy

- diagnosis of chronic glaucoma was based on the following:

- IOP ≥ 25 mm Hg

- absent menace response and dazzle reflexes

- ocular changes, including the following:

- episcleral injection

- buphthalmos

- corneal edema

- secondary lens luxation or subluxation

- posterior segment changes noted included the following:

- optic nerve atrophy

- optic disk cupping

- retinal vascular attenuation

- intravitreal gentamicin

- with or without dexamethasone sodium phosphate or triamcinolone

- 3 month minimum followup

- exclusion criteria:

- previous glaucoma surgery

- previous diagnosis of intraocular neoplasia

- history and signalment

- mean age of the 108 dogs in study at time of the procedure:

- 9.5 ± 2.7 years with a range of 2-16 years

- breeds represented by 5 or more cases

- cocker spaniel, overrepresented with 24 cases

- shih tzu, 8

- Labrador retriever, 6

- Siberian husky, 5

- Bichon Frise, 5

- procedure: records between 2013 and 2018 retrospectively reviewed

- 1 eye from bilateral cases randomly selected for analysis

- success defined as intraocular pressure ≤ 25 mm Hg at last re-examination

- or no ocular hypotensive medications at 3 months or longer post-injection

- diagnosis of canine primary glaucoma based on the following:

- elevated intraocular pressure

- optic nerve changes

- lack of readily identifiable concurrent ocular or systemic diseases

(on routine ophthalmic examination)

- causes of secondary glaucoma included the following:

- hypermature cataracts

- lens luxation

- pigmentary uveitis

- cataract surgery

- retinal detachment

- chronic uveitis

- lipid uveitis

- trauma

- procedure (dogs had sedation or anesthesia for bilateral procedures)

- intended eye(s) aseptically prepared with 0.5% betadine solution

- topical proparacaine hydrochloride 0.5% applied

- followed by topical phenylephrine 2.5%

- for conjunctival and episcleral hemostasis

- vitreocentesis using 25 gauge, 1-inch hypodermic needle

- inserted 6-8 mm posterior to the limbus to reduce IOP

- 0.5-0.6 mL of vitreous aspirated

- followed by 30-50 mg of gentamicin (100 mg/mL)

(1 ophthalmologist based dose on dog’s weight and another used

a standard dose of 30 mg)

- combined with 1 of the following:

(for injection-related inflammation)

- 0.4 mg of dexamethasone sodium phosphate (4 mg/mL)

 or

- 1-2 mg of triamcinolone (2 mg/mL)

- immediate post-injection IOP recorded

- if IOP remained ≥ 25 mm Hg, aqueocentesis performed

- using 27-30 gauge, 1-inch hypodermic needle

   

Results

- overall success rate: 95%

- success rate for dogs receiving no ocular hypotensive medications: 86%

- type of glaucoma in the 108 eyes

- 76 eyes (70.4%) had primary glaucoma

- 32 (29.6%) had secondary glaucoma

- cataract surgery, 14 eyes

- hypermature cataracts, 6

- pigmentary uveitis, 4

- retinal detachment, 3

- anterior lens luxation, 2

- single eyes with either anterior uveitis, trauma, or lipid uveitis, 0.9%

- effect of age at the time of injection

- no effect on initial success

- did effect final success for dogs requiring repeat injections

- all cases that needed repeat injections were 6 years or older

- 12 dogs required a 2nd intravitreal injection

- at a mean of 208 ± 157.9 days after the first

- 3rd injection, 4 dogs

- cocker spaniels required the most repeat injections

(3 of 12 required a 2nd injection and 2 of 4 required a 3rd injection)

- no preoperative variable found to significantly affect the success rate

- including type of steroid used and the dose of both steroid and gentamicin

- complications

- phthisis bulbi, 59.2%

- corneal edema, 25.9%

- ulcerative keratitis, 22.3%

- subconjunctival hemorrhage, 9.2%

- hyphema, 8.3%

- cataracts, 6.4%

- endophthalmitis, 3%

- enucleation due to uncontrolled IOP, 2 dogs

   

“Primary versus secondary glaucoma cases did not show a difference in the success rate. Moreover, neither lens luxation as a cause of secondary glaucoma nor chronicity of disease affected the success rate.”

Keywords
canine; ciliary body ablation; gentamicin; glaucoma; intravitreal injection; pharmacologic ablation;

Article Tools:
   Medline
   Email to me

Grants:
BluePearl Science

Archives Highlights:
Performing an Avian Physical Examination in Practice
As with mammalian physical examinations, it is important to develop a consistent order for the avian examination to thoroughly evaluate each body system. Some components of the physical examination differ between avian species. For example, cloacal palpation is performed in chickens, but not in parrots.
Canine distemper outbreak and laryngeal paralysis in captive tigers (Panthera tigris).
All suspected and confirmed cases of CDV infections were significantly associated with laryngeal inflammation, which developed into paralysis in almost 50% of cases. Altogether, 50% of all tiger cases with chronic infection developed stridor at 314 days after virus infection. Therefore, laryngeal paralysis may result from CDV infection and degeneration, potentially affecting the peripheral and central nervous systems. This condition could pose a life-threatening risk to tigers.
[Disease Caused by Filoviruses: An Update].
The Marburg and Ebola viruses belong to the Filoviridae family and are known to cause emerging zoonotic diseases. These viruses have a high case fatality rate and are easily transmissible from person to person, which makes them capable of triggering outbreaks, including in non-endemic regions, and are also considered agents of bioterrorism. This review aims to improve clinical knowledge and the approach to suspected cases of FD. Improved surveillance and preparedness for potential global outbreaks are essential measures to effectively respond to these public health threats and to ensure that healthcare professionals are well-informed and prepared to deal with these diseases.
'Transmission Tracker - Dirofilaria'- a public dashboard to assess in real-time the temperature-bounded transmissibility of canine heartworm across Australia.
'Transmission Tracker - Dirofilaria' processes near real-time temperature records across Australia and allows users to enquire about historical and current weather suitability for canine heartworm transmission at any Australian postcode of their interest. This information allows veterinarians to access when, and for how long, heartworm may be transmitted at a specific location, assess the associated risk of infection, and advise on a patient-dependent dirofilariosis prevention plan for their canine patients and guardians.
A public health campaign to increase awareness of the risk of dog bites in South Australia.
Over one third (36-37%) of dog owners and 25-29% of non-dog owners had been previously bitten by a dog, although most did not require medical attention. Approximately 70% of dog owners believed it was safe for strangers to approach their dog, 34-37% allowed children or other people to pat their dog without permission, and less than half separated their dog from visitors or delivery people. In contrast, few of the non-dog owners allowed their children to pat a dog without the owner's permission and only 2% allowed them to play with dogs without supervision.

Back Print Save Bookmark in my Browser Email this article to me. Top of Page. VSPN AOW : Pharmacologic ciliary bod...
Contact Us